Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15.
Abdolkarim Sheikhi(Dezful University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Abdollah Jafarzadeh(Kerman University of Medical Sciences), Parviz Kokhaei(Arak University of Medical Sciences)
Cited by 27
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
CDK1 in Breast Cancer: Implications for Theranostic Potential
|Anti-Cancer Agents in Medicinal Chemistry|2020|169
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
|Journal of Cellular Physiology|2017|150